Pharmaceutical Contract Manufacturing Organization
Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients’ needs.
Your Partner for Nasal Sprays
State-of-the-art laboratory
Cutting edge spray characterization instruments, almost 20 years in nasal experience, and successful commercialization of products for the US and global markets, Renaissance is the “one-stop-shop” for all your nasal spray formulation, development, testing, and commercialization needs.
LEARN MORETrusted, Reliable Contract Manufacturing
World-class sterile liquid manufacturing
Renaissance is a global, pure-play contract development and manufacturing organization (“CDMO”) leader with an unparalleled bench-to-shelf service offering for nasal and sterile injectable dosage forms.
LEARN MORE1979
Where it all started. Paco Packaging & Labs relocates to Paco Way in Lakewood, NJ from Philadelphia, PA.
LEARN MORE
News & Events

September 13, 2023
RENAISSANCE LAKEWOOD, LLC ANNOUNCES NEW LABORATORY FACILITIES
LAKEWOOD, NJ (9/13/23) – Renaissance Lakewood, LLC, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced a significant expansion of their Quality Control Spray/Particulate Laboratory as well as both of their Analytical and Formulation Research and Development laboratories in Ocean County, NJ.
READ MORE
August 23, 2023
CPHI Worldwide 2023
JOIN US AT THE EVENT FOR THE PHARMA INDUSTRY at Booth #80B20.
READ MORE
March 4, 2023
Renaissance Lakewood, LLC invests in additional high-speed nasal spray assembly and packaging capability
Renaissance recently completed the installation and qualification of a new high-speed nasal spray assembly line capable of assembling and packaging unit-dose and bi-dose nasal spray devices at speeds of up to 200 units per minute. This new state-of-the-art line combines the nasal spray assembly, labeling, blister packaging, cartoning, serialization and case packing to create a highly efficient and high-quality manufacturing process for unit-dose and bi-dose nasal spray devices.
READ MORE+$30m
+$30 million in facilities and equipment investments since 2020
1st
Manufacturer of the first FDA approved bi-dose nasal spray drug
310k
Sq. ft. of infrastructure with additional space under construction
+10
cGMP manufacturing suites with additional under construction